This grant offered by the National Institutes of Health supports projects utilizing omics technologies to enhance preventative and/or therapeutic HIV vaccinations and immunomodulatory interventions. Applicants are encouraged to integrate omics, computational, and experimental approaches to study immune responses to HIV. The aim is to contribute to the development of effective vaccination and cure strategies for HIV. Closing date for applications is October 13, 2022.
General Information
| Document Type:: |
Grants Notice |
| Funding Opportunity Number:: |
RFA-AI-22-038 |
| Funding Opportunity Title:: |
A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed) |
| Opportunity Category:: |
Discretionary |
| Opportunity Category Explanation:: |
|
| Funding Instrument Type:: |
|
| Category of Funding Activity:: |
Education |
| Category Explanation:: |
|
| Expected Number of Awards:: |
|
| Assistance Listings Number(s):: |
93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement:: |
No |
| Version:: |
Synopsis 1 |
| Posted Date:: |
May 27, 2022 |
| Last Updated Date:: |
May 27, 2022 |
| Original Closing Date for Applications:: |
Oct 13, 2022 |
| Current Closing Date for Applications:: |
Oct 13, 2022 |
| Archive Date:: |
Nov 18, 2022 |
| Estimated Total Program Funding:: |
|
| Award Ceiling:: |
$1,000,000 |
| Award Floor:: |
$ |
Eligibility
| Eligible Applicants:: |
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility:: |
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name:: |
National Institutes of Health |
| Description:: |
The purpose of this Funding Opportunity Announcement (FOA) is to support multi-disciplinary, multi-component applications proposing the use of omics technologies to advance preventative and/or therapeutic vaccinations, and/or immunomodulatory cure interventions for HIV. Projects will integrate omics, computational, and hypothesis-driven experimental approaches to interrogate immune responses to HIV vaccination and/or cure strategies. |
| Link to Additional Information:: |
|
| Grantor Contact Information:: |
If you have difficulty accessing the full announcement electronically, please contact: |
Version History
| Version |
Modification Description |
Updated Date |
| Synopsis 1 |
|
May 27, 2022 |
Package Status
Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:
Package No: 1
Packages
| Assistance Listings |
Competition ID |
Competition Title |
Opportunity Package ID |
Opening Date |
Closing Date |
Actions |
Who Can Apply: |
|
FORMS-G |
Use for due dates on or after January 25, 2022 |
PKG00274682 |
Sep 13, 2022 |
Oct 13, 2022 |
View |
eRA Service Desk Monday to Friday 7 am to 8 pm ET http://grants.nih.gov/support/ |
Organization Applicants |
